Market Indices
Latest News
 |
DBV Technologies S.A. (DBVT) confirmed earnings release on March 24, 2026,...
March 23, 2026 DBVT 2.12% |
| ||
| ||
| ||
|
Price Targets
Roger Song from Jefferies issued a price target of $16.00 for CTMX on 2026-03-18 14:16:00.The adjusted price target was set to $16.00.At the time of the announcement, CTMX...
March 18, 2026 CTMX 0.36%
Stephen Willey from Stifel Nicolaus issued a price target of $17.00 for ABEO on 2026-03-17 19:53:00.The adjusted price target was set to $17.00.At the time of the announcement,
March 17, 2026 ABEO -0.56%
Michael Baker from D.A. Davidson issued a price target of $68.00 for CTRN on 2026-03-17 19:35:00.The adjusted price target was set to $68.00.At the time of the announcement,
March 17, 2026 CTRN 5.27%
Greg Renza from Truist Financial issued a price target of $12.00 for CATX on 2026-03-17 12:35:00.The adjusted price target was set to $12.00.At the time of the announcement,
March 17, 2026 CATX -5.96%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| SYRS Syros Pharmaceuticals, In | 0.00
300.00% | ||||||||||||||||||
| SATL Satellogic Inc. | 4.97
38.49% | ||||||||||||||||||
| ALDX Aldeyra Therapeutics, Inc | 2.27
25.14% | ||||||||||||||||||
| LICN Lichen International Limi | 3.69
25.08% | ||||||||||||||||||
| RDIB Reading International, In | 9.80
22.50% | ||||||||||||||||||
| SLND Southland Holdings, Inc. | 1.12
21.90% | ||||||||||||||||||
| ARBEW Arbe Robotics Ltd. Warran | 0.06
21.42% | ||||||||||||||||||
| BNGO Bionano Genomics, Inc. | 1.39
20.43% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP 8.43%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -34.96%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE 3.56%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK 2.09%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN 3.84%